{
    "url_original": "https://www.wsj.com/articles/risk-management-and-the-formula-crisis-baby-infant-aisles-stores-supply-chain-food-11652882318?mod=opinion_lead_pos5",
    "url": "risk-management-and-the-formula-crisis-baby-infant-aisles-stores-supply-chain-food-11652882318",
    "title": "Risk Management and the Baby-Formula Shortage",
    "sub_head": "The FDA should have had preapproved alternative suppliers as part of a supply-chain strategy.",
    "category_1": "Opinion",
    "category_2": "Commentary",
    "image_1_url": "https://images.wsj.net/im-546680?width=860&height=573",
    "image_1": "im-546680.jpg",
    "time": "2022-05-18 13:20:00"
}